Top Institutions in Ophthalmology - Diabetic Retinopathy and Retinal Ischemia
Leading institutions in this area conduct early-phase clinical trials, advanced retinal imaging studies, and translational research on vascular and neurodegenerative mechanisms in diabetic retinopathy and glaucoma, often pioneering novel drug delivery systems such as sustained-release intravitreal implants.
-
#1
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in diabetic retinopathy research with extensive clinical trial programs and pioneering work in retinal imaging and novel therapeutics, including intravitreal drug delivery systems.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its expertise in diabetic retinopathy and retinal vascular diseases, with a strong focus on translational research and clinical trials of novel pharmacologic agents.
-
#3
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Mass Eye and Ear is a premier center for retinal research, combining clinical expertise with cutting-edge research in retinal ischemia and neuroprotection, including novel drug delivery implants.
-
#4
University of Nevada, Reno School of Medicine / Sierra Eye Associates
Reno, NV
Led by Dr. Arshad Khanani, this institution is pioneering clinical research on novel endothelin antagonists like PER-001, with early-phase trials demonstrating functional improvements in diabetic retinopathy.
-
#5
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal vascular disease research and clinical trials, with a strong emphasis on innovative therapies for diabetic retinopathy and retinal ischemia.
